Mr. Gerri Greenham reports

SOLARVEST BIOENERGY INC. ANNOUNCES $2,000,000 PRIVATE PLACEMENT UNIT FINANCING

Solarvest Bioenergy Inc. has arranged a private placement, pursuant to which the company intends to raise gross proceeds of up to $2-million through the issuance of up to 10 million units at a price of 20 cents per unit. Each unit consists of one common share and one whole share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share of the company at a price of 25 cents per share for a period of three years following closing. The company will pay finders' fees in the amount of 8 per cent in cash and 8 per cent in warrants at the same term of the private placement. Closing may take place in two or more tranches.

The company has applied to the TSX Venture Exchange for immediate approval to close a first tranche of 2.2 million units for proceeds of $440,000.

Proceeds from the private placement will be used for the production of inventory, sales and marketing, equipment purchases, patenting costs, and general working capital. All securities issued pursuant to the private placement are subject to resale restrictions for a period of four months and one day from closing under applicable securities legislation.

About Solarvest Bioenergy Inc.

Solarvest Bioenergy is an alga technology company whose algal-based production platform provides it with an extremely flexible system capable of being adapted to produce numerous products -- from omega-3 fatty acids to human therapeutic proteins. The company has demonstrated (news release dated March 16, 2015) the expression of BMP, a high-value therapeutic protein. In addition, the company's platform has produced recombinant viral antigens (immune stimulating proteins) Cecropins (anti-microbial pepetide/protein). The company has completed a feasibility study for the expression of CBD (cannabidiol) and THC (tetrahydrocannabinol) as a way to produce CBD and THC in sterile bioreactors.

We seek Safe Harbor.